Literature DB >> 9557838

The effect of colchicine treatment on sperm production and function: a review.

R Haimov-Kochman1, E Ben-Chetrit.   

Abstract

Colchicine is used for the treatment of various diseases including gouty arthritis, familial Mediterranean fever (FMF) and Behcet's disease. As a modulator of the microtubules at the cytoskeleton level, it arrests cell division at metaphase and inhibits microtubular-dependent cell motility. Controversy exists as to the adverse effect of colchicine on sperm production and function in healthy subjects as well as in gout, FMF and Behcet's patients. Sperm analysis shows a spectrum of pathology, from oligo- and azoospermia to normospermia with disturbances in sperm motility. These inconsistent sperm pathologies can be explained in part by the variability of the pathophysiology of the underlying disease. Thus, it seems that colchicine by itself may not have a significant direct adverse effect on sperm production and function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557838     DOI: 10.1093/humrep/13.2.360

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

Review 1.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

Review 2.  FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.

Authors:  Elizabeth R Rayburn; Liang Gao; Jiayi Ding; Hongxia Ding; Jun Shao; Haibo Li
Journal:  J Assist Reprod Genet       Date:  2017-10-24       Impact factor: 3.412

3.  The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever.

Authors:  Mustafa Yildiz; Seval Masatlioglu; Pinar Seymen; Erman Aytac; Banu Sahin; H Oktay Seymen
Journal:  Can J Cardiol       Date:  2006-11       Impact factor: 5.223

4.  Defective expression of Galpha12 in the testes of azoospermia patients and in the spermatozoa with low motility.

Authors:  Yanqiu Hu; Ying Lu; Zuomin Zhou; Yong Du; Jun Xing; Lei Wang; Min Lin; Jiahao Sha
Journal:  J Mol Med (Berl)       Date:  2006-04-13       Impact factor: 4.599

Review 5.  [New aspects of rare rheumatic diseases during pregnancy].

Authors:  Jörg Henes; Ann-Christin Pecher
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.372

Review 6.  Reproductive system in familial Mediterranean fever: an overview.

Authors:  E Ben-Chetrit; M Levy
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 7.  The influence of bioactive oxylipins from marine diatoms on invertebrate reproduction and development.

Authors:  Gary S Caldwell
Journal:  Mar Drugs       Date:  2009-08-21       Impact factor: 5.118

8.  Safety of colchicine therapy during pregnancy.

Authors:  Ong Michael; Ran D Goldman; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-08       Impact factor: 3.275

Review 9.  FDA-approved medications that impair human spermatogenesis.

Authors:  Jiayi Ding; Xuejun Shang; Zhanhu Zhang; Hua Jing; Jun Shao; Qianqian Fei; Elizabeth R Rayburn; Haibo Li
Journal:  Oncotarget       Date:  2017-02-07

10.  [Colchicine: old medication with new benefits : Use in rheumatology and beyond].

Authors:  Z Boyadzhieva; N Ruffer; M Krusche
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.